Patents by Inventor Wanqiang Sheng

Wanqiang Sheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER USING LSD1 INHIBITORS IN COMBINATION WITH IMMUNOTHERAPY
    Publication number: 20240018242
    Abstract: Provided herein are methods of treating cancer using LSD1 inhibitors in combination with immunotherapy.
    Type: Application
    Filed: May 17, 2023
    Publication date: January 18, 2024
    Inventors: Yang Shi, Wanqiang Sheng, Arlene H. Sharpe, Martin W. LaFleur
  • Methods of treating cancer using LSD1 inhibitors in combination with immunotherapy
    Patent number: 11685782
    Abstract: Provided herein are methods of treating cancer using LSD1 inhibitors in combination with immunotherapy.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: June 27, 2023
    Assignees: Children's Medical Center Corporation, President & Fellows of Harvard College
    Inventors: Yang Shi, Wanqiang Sheng, Arlene H. Sharpe, Martin W. LaFleur
  • Methods and Compositions for Modulating TH-GM Cell Function
    Publication number: 20200408757
    Abstract: Disclosed herein is a T-helper cell (“TH-GM” cell) that is regulated by IL-7/STAT5 and which secrete GM-CSF/IL-3. Also disclosed are methods and compositions for modulating TH-GM function for the treatment of, e.g., inflammatory disorders. Diagnostic and prognostic methods for specifically identifying TH-GM-mediated inflammatory disorders (e.g., rheumatoid arthritis), as distinct from and/or in addition to non-TH-GM-mediated (e.g., TNF-?-mediated) inflammatory disorders, are also provided.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 31, 2020
    Applicant: National University of Singapore
    Inventors: Xin-yuan FU, Wanqiang SHENG, Yongliang ZHANG, Fan YANG
  • METHODS OF TREATING CANCER USING LSD1 INHIBITORS IN COMBINATION WITH IMMUNOTHERAPY
    Publication number: 20200255527
    Abstract: Provided herein are methods of treating cancer using LSD1 inhibitors in combination with immunotherapy.
    Type: Application
    Filed: October 23, 2018
    Publication date: August 13, 2020
    Inventors: Yang Shi, Wanqiang Sheng, Arlene H. Sharpe, Martin W. LaFleur
  • Methods and compositions for modulating T-GM cell function
    Patent number: 10690666
    Abstract: Disclosed herein is a T-helper cell (“TH-GM” cell) that is regulated by IL-7/STAT5 and which secrete GM-CSF/IL-3. Also disclosed are methods and compositions for modulating TH-GM function for the treatment of, e.g., inflammatory disorders. Diagnostic and prognostic methods for specifically identifying TH-GM-mediated inflammatory disorders (e.g., rheumatoid arthritis), as distinct from and/or in addition to non-TH-GM-mediated (e.g., TNF-?-mediated) inflammatory disorders, are also provided.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: June 23, 2020
    Assignee: NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Fu Xin-Yuan, Wanqiang Sheng, Yongliang Zhang, Fan Yang
  • Methods and Compositions for Modulating TH-GM Cell Function
    Publication number: 20170219581
    Abstract: Disclosed herein is a T-helper cell (“TH-GM” cell) that is regulated by IL-7/STAT5 and which secrete GM-CSF/IL-3. Also disclosed are methods and compositions for modulating TH-GM function for the treatment of, e.g., inflammatory disorders. Diagnostic and prognostic methods for specifically identifying TH-GM-mediated inflammatory disorders (e.g., rheumatoid arthritis), as distinct from and/or in addition to non-TH-GM-mediated (e.g., TNF-?-mediated) inflammatory disorders, are also provided.
    Type: Application
    Filed: September 25, 2015
    Publication date: August 3, 2017
    Applicant: National University of Singapore
    Inventors: Fu Xin-Yuan, Wanqiang Sheng, Yongliang Zhang, Fan Yang